Employees Retirement System of Texas’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$113M Sell
448,200
-7,600
-2% -$1.64M 0.9% 28
2026
Q1
$99.1M Buy
+455,800
New +$101M 0.87% 30
2023
Q1
Sell
-114,000
Closed -$18.4M 331
2022
Q4
$18.4M Sell
114,000
-125,000
-52% -$19.2M 0.27% 119
2022
Q3
$32.1M Sell
239,000
-81,313
-25% -$11.7M 0.49% 52
2022
Q2
$49.1M Hold
320,313
0.7% 25
2022
Q1
$51.9M Sell
320,313
-38,900
-11% -$5.65M 0.62% 24
2021
Q4
$48.6M Hold
359,213
0.54% 29
2021
Q3
$38.7M Buy
359,213
+38,900
+12% +$4.44M 0.45% 39
2021
Q2
$36.1M Hold
320,313
0.44% 40
2021
Q1
$34.7M Hold
320,313
0.45% 44
2020
Q4
$34.3M Buy
320,313
+21,000
+7% +$2.02M 0.54% 33
2020
Q3
$26.2M Sell
299,313
-49,855
-14% -$4.69M 0.38% 46
2020
Q2
$34.3M Buy
349,168
+55,813
+19% +$4.91M 0.52% 32
2020
Q1
$22.4M Buy
293,355
+48,855
+20% +$4.16M 0.43% 48
2019
Q4
$21.6M Buy
244,500
+58,000
+31% +$4.82M 0.34% 64
2019
Q3
$14.1M Sell
186,500
-57,900
-24% -$3.97M 0.22% 109
2019
Q2
$17.8M Sell
244,400
-5,000
-2% -$393K 0.27% 79
2019
Q1
$20.1M Buy
249,400
+33,000
+15% +$2.7M 0.3% 66
2018
Q4
$19.9M Sell
216,400
-60,000
-22% -$5.28M 0.32% 63
2018
Q3
$26.1M Sell
276,400
-17,000
-6% -$1.61M 0.35% 57
2018
Q2
$27.2M Buy
293,400
+25,700
+10% +$2.51M 0.37% 50
2018
Q1
$25.3M Sell
267,700
-64,400
-19% -$7.07M 0.34% 56
2017
Q4
$32.1M Buy
332,100
+83,000
+33% +$7.82M 0.41% 44
2017
Q3
$22.1M Buy
249,100
+41,000
+20% +$3.12M 0.29% 71
2017
Q2
$15.1M Sell
208,100
-3,000
-1% -$202K 0.2% 105
2017
Q1
$13.8M Sell
211,100
-108,000
-34% -$6.79M 0.19% 112
2016
Q4
$20M Sell
319,100
-159,500
-33% -$9.74M 0.27% 82
2016
Q3
$30.2M Sell
478,600
-327,000
-41% -$21.2M 0.41% 47
2016
Q2
$49.9M Buy
805,600
+177,300
+28% +$10.8M 0.68% 21
2016
Q1
$35.9M Sell
628,300
-49,000
-7% -$2.73M 0.5% 37
2015
Q4
$40.1M Sell
677,300
-27,900
-4% -$1.61M 0.56% 33
2015
Q3
$38.4M Sell
705,200
-103,000
-13% -$6.7M 0.55% 30
2015
Q2
$54.3M Buy
808,200
+76,000
+10% +$4.96M 0.71% 17
2015
Q1
$42.9M Buy
732,200
+319,000
+77% +$19.3M 0.55% 27
2014
Q4
$27M Sell
413,200
-282,000
-41% -$17.8M 0.34% 68
2014
Q3
$40.2M Sell
695,200
-27,464
-4% -$1.52M 0.53% 36
2014
Q2
$40.8M Buy
722,664
+296,364
+70% +$15.5M 0.52% 29
2014
Q1
$21.9M Sell
426,300
-353,000
-45% -$17.8M 0.29% 72
2013
Q4
$41.2M Buy
779,300
+180,850
+30% +$8.89M 0.53% 33
2013
Q3
$26.8M Sell
598,450
-31,650
-5% -$1.4M 0.33% 51
2013
Q2
$26M Buy
+630,100
New +$27.6M 0.31% 50

Other funds holding ABBV

Employees Retirement System of Texas's ABBV Position: Q2 2026 in Review

Employees Retirement System of Texas reduced its AbbVie (ABBV) stake by 1.7% in Q2 2026, selling an estimated $1.64M and leaving 448,200 shares worth $113M. The position accounts for 0.9% of the portfolio, ranked #28.

Employees Retirement System of Texas first reported a position in ABBV in Q2 2013 and has held it in 41 quarters since. 4,188 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Employees Retirement System of Texas held 448,200 shares of AbbVie worth $113M as of Q2 2026.
  • Employees Retirement System of Texas sold 7,600 AbbVie shares in Q2 2026, an estimated $1.64M.
  • AbbVie made up 0.9% of Employees Retirement System of Texas's portfolio in Q2 2026, its #28 holding.
  • Employees Retirement System of Texas first reported a position in AbbVie in Q2 2013 and has held it in 41 quarters since.
  • 4,188 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Employees Retirement System of Texas's 13F filing for Q2 2026, filed 14 Aug 2026.